Article

Assessing the Androgen Receptor Status in Clinicopathologic and Hematologic Characteristics of the Triple-negative Breast Cancer

2025-11-13

Abstract excerpt

<title>Abstract</title> <p>Background Triple-negative breast cancer (TNBC) is an aggressive subtype with significant treatment challenges. Emerging evidence suggests that the androgen receptor (AR) may play a key role in prognosis, but findings are inconsistent. This study aimed to clarify the relationship between AR status and TNBC while examining associated clinicopathologic, hematologic, and demographic factor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dce04874-b3e7-5232-9203-c7e26a3634e8
DOI: 10.21203/rs.3.rs-7771474/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Assessing the Androgen Receptor Status in Clinicopathologic and Hematologic Characteristics of the Triple-negative Breast CancerDOI 10.21203/rs.3.rs-7771474/v1Read

Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.Semantic proximity Read

Molecular subtypes of triple-negative breast cancer: understanding of subtype categories and clinical implication.Semantic proximity Read

Prognostic value of androgen receptor expression and molecular alterations in metastatic triple-negative or low hormone receptor breast carcinomas.Semantic proximity Read

Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast CancerSemantic proximity Read

[Androgen receptor-positive triple negative breast cancer: From biology to therapy].Semantic proximity Read

Divide and Conquer—Targeted Therapy for Triple-Negative Breast CancerSemantic proximity Read

Looking beyond the ER, PR, and HER2: what’s new in the ARsenal for combating breast cancer?Semantic proximity Read

The hormone receptor status in breast cancer and the relationship of subtypes with clinicopathological features.Semantic proximity Read

Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profilingSemantic proximity Read

Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations.Semantic proximity Read

Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide <i>In Vivo</i>Semantic proximity Read

Clinicopathological Characterization of HER2-Low-Expressing Triple-Negative Breast Cancer: Distinct Features From HER2-Zero Subtype.Semantic proximity Read